Ingos Gruzdienės sveikatos priežiūros centras, MB - financials and debts
Company age: 11 y. 4 mo.
Ingos Gruzdienės sveikatos priežiūros centras - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 348,391 | 360,234 | 588,155 | 674,382 | 668,451 | 850,937 | 1,134,635 | 1,430,164 |
| Profit before tax | 18,845 | 11,182 | 92,969 | 132,413 | 202,825 | 294,025 | 488,651 | 596,784 |
| Net profit | 16,193 | 9,449 | 78,713 | 111,148 | 176,608 | 249,786 | 414,723 | 500,125 |
| Equity | 315,911 | 325,172 | 404,135 | 515,282 | 568,902 | 631,141 | 549,472 | 368,400 |
| Liabilities | - | - | - | - | 161,722 | 212,721 | 170,283 | 146,394 |
| Non-current assets | 599,821 | 880,476 | 754,272 | 676,930 | 550,230 | 606,914 | 588,346 | 458,554 |
| Current assets | 54,754 | 29,988 | 83,212 | 86,154 | 180,394 | 236,948 | 131,409 | 56,240 |
| Total assets | 654,575 | 910,464 | 837,484 | 763,084 | 730,624 | 843,862 | 719,755 | 514,794 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 100,102 | 191,830 | 267,917 |
| Social insurance contributions | - | - | - | - | - | 34,513 | 26,951 | 25,987 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +23.4% | +3.4% | +63.3% | +14.7% | -0.9% | +27.3% | +33.3% | +26.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.5% | 1.0% | 9.4% | 14.6% | 24.2% | 29.6% | 57.6% | 97.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 5.1% | 2.9% | 19.5% | 21.6% | 31.0% | 39.6% | 75.5% | 135.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 4.6% | 2.6% | 13.4% | 16.5% | 26.4% | 29.4% | 36.6% | 35.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.4% | 3.1% | 15.8% | 19.6% | 30.3% | 34.6% | 43.1% | 41.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | 0.3 | 0.3 | 0.3 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 348,391 | 172,915 | 72,019 | 65,793 | 58,126 | 67,624 | 162,091 | 225,817 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ingos Gruzdienės sveikatos priežiūros centras - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2022-07-01 | 2022-07-03 | 17.45 |
Ingos Gruzdienės sveikatos priežiūros centras - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-03-02 | 2026-03-11 | 5.65 |
| 2026-02-21 | 2026-02-21 | 4.35 |
| 2026-01-29 | 2026-02-16 | 4.35 |
| 2026-01-08 | 2026-01-08 | 1111.57 |
| 2025-08-31 | 2025-09-02 | 7.66 |
| 2025-08-28 | 2025-08-30 | 7.82 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ingos Gruzdienes sveikatos priežiuros centras, MB, company code 304038649, is a Small partnership operating in diagnostic imaging services and medical laboratory activities. In the latest financial year, 2025, revenue increased to €1.43M, up 26.1% year on year and 68.1% over two years. Net profit reached €500.1K, with a profit margin of 35.0%, after €414.7K in 2024 and €249.8K in 2023. The three-year trajectory shows steady top-line growth and a consistent rise in absolute profit. Balance sheet totals weakened over the same period, with total assets declining from €843.9K in 2023 to €719.8K in 2024 and €514.8K in 2025. Equity also fell from €631.1K to €368.4K, while liabilities decreased from €212.7K to €146.4K. Even so, the equity ratio remained high at 71.6%, and debt-to-equity stood at 0.40. Asset turnover was 2.78x in 2025, and revenue per employee was €238.4K, indicating strong operating productivity.